Surveillance of toxoplasmosis in pregnant women in Albania

New Microbiologica

Volumn 32, Issue 1, 2009, Pages 89-92

  Maggi, Paolo ^a   Volpe, Anna ^a   Carito, Valentina ^a   Schinaia, Nicola ^b   Bino, Silva ^c   Basho, Mimoza ^c   Dentico, Pietro ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c National Institute of Albanian Health   (Albania)

Author keywords

IgG; IgM; Pre garvidic screening; Pregnancy; Serological test; Toxoplasmosis

Indexed keywords

PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ALBANIA; ANIMAL; ANTIBODY AFFINITY; ARTICLE; BLOOD; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PARASITOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; TOXOPLASMA; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ALBANIA; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; FEMALE; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

TOXOPLASMA;

EID: 62149138965     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ALLAIN J.P., PALMER C.R., PEARSON G. (1998). Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from regional population in the UK. J Infect 36, 189-196.
2. BOBIC B., JEVREMOVIC I., MARINKOVIC J., SIBALIC D., DJURKOVIC-DJAKOVIC O. (1998). Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia. Eur J Epidemiol. 14 (6), 605-610.
3. BOBIC B., NIKOLIC A., DJURKOVIC-DJAKOVIC O. (2003). Identification of risk factors for infection with Toxoplasma gondii in Serbia as a basis of a program for prevention of congenital toxoplasmosis. Srp Arh Celok Lek. 131 (3-4), 162-167.
4. BOWIE WR, KING AS, WERKER DH., ISAAC-RENTON JL, BELL A, ENG SB, MARION SA. (1997) Toxoplasma Investigation Team. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet 350, 173-177.
5. DE PASCHALE M., AGRAPPI C., BELVISI L., CAGNIN D., CERULLI T., CLERICI P., MIRRI P., MANCO M.T., CAVALLAI S, VIGANO F.F. (2008). Revision of the positive predictive value of IgM anti-Toxoplasma antibodies a san index of the recent infection. New Microbiol. 31 (1), 105-111.
6. EVENGARD B., PETERSSON K., ENGMAN M.L., WIKLUND S., IVARSSON S.A., TEAR-FAHNEHJELM K., FORSGREN M., GILBERT R., MALM G. (2001). Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect. 127, 121-127.
7. GALVAN-RAMIREZ M.L., GUILLEN-VARGAS C., SAAVEDRA-DURAN R., ISLOS-RODRIGUEZ A. (1998). Analysis of Toxoplasma gondii antigens with sera from toxoplasmosis patients. Revista da Sociedade Brasiliera de Medicina Tropical 31, 271-277.
8. GILBERT R. (1999). Epidemiology of infection in pregnant women. In: Petersen E. & Amboise-thomas P., eds Congenital toxoplasmosis: scientific background, clinical management and control. Paris: SpringerVerlag France.
9. HORION M., THOUMSIN H., SENTERRE J., LAMBOTTE R. (1990). 20 years of screening for toxoplasmosis in pregnant women. The Liege experience in 20,000 pregnancies. Rev Med Liege 45, 492-497.
10. JENUM P.A., KAPPERUD G., STRY PEDERSEN B., MELBY K.K., ESKILD A., ENG J. (1998). Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 120, 87-92.
11. LEBECH M., ANDERSEN O., CHRISTENSEN N.C., HERTEL J., NIELSEN H.E., PEITERSEN B., RECHNITZER C., LARSEN S.O., NORGAARD-P ETERSEN E. (1999). Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 353, 1834-1837.
12. MCCABE R.E., REMINGTON J.S. (1988). Toxoplasmosis: the time has come. The New England Journal of Medicine. 318, 313-315.
13. SPALDING S.M., AMENDOEIRA M.R.R., KLEIN C.H., RIBEIRO L.C. (2005). Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev. Soc. Bras. Med. Trop. 38 (2), 173-177.
14. TIZARD J.R., CHAUHAN S.S., LAI C.H. (1977). The prevalence and epidemiology of toxoplasmosis in Ontario. J. Hyg. (Lond) 78 (2), 275-282.
15. WILLIAMS K.A.B., SCOTT J.M., MACFARLANE D.E., WILLIAMS J.M., ELIASJONES T.F., WILLIAMS H. (1981). Congenital toxoplasmosis: a prospective survey in the West of Scotland. J. Infect. 3, 219-229.
16. WONG S.Y., REMINGTON J.S. (1994). Toxoplasmosis in pregnancy. Clin. In.f Dis. 18, 853-862.
17. ZOTTI C., CHARRIER L., GIACOMUZZI M., MOIRAGHI RUGGENINI A., MOMBRÒ M., FABRIS C. MAROCCHETTI P., ALFIERI R., LETO R., RENZI N., MILANO R., LIEVE M.A., COLOZZA M., ZANELLA D., ANTONA G., MASCHERO M.C., TOSETH F., BIGLIETTI D., NICOLETTA T., DE RENZI G., TINTVELLA F., DONATI M., FERRINI A., CROTTI G., COUCOURDE L., GUAZZETTI G.C., GERA A., MALABAILA A., DE NATALE C., RABOZZI M.L., GINARDI C., BUZZONE T., CANEPA C., FRUTTERO M., MASTRACCHIO G., VALLE S., TOPPING M., FORNO N., BELLINGERI P., CARACCIO W., LAZZARA C., DECAROLI V., PEDRAZZI E., GOMELLA S., COLLABORATING GROUP. (2004). Use of IgG Avidità test in case definitions of toxoplasmosis pregnancy. New Microbiol. 27 (1), 17-20.